Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T11388 | Target Info | |||
Target Name | Cathepsin K (CTSK) | ||||
Synonyms | Cathepsin X; Cathepsin O2; Cathepsin O; CTSO2; CTSO | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CTSK | ||||
Biochemical Class | Peptidase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 2-[(2-Carbamoylsulfanylacetyl)amino]benzoic acid | Ligand Info | |||
Canonical SMILES | C1=CC=C(C(=C1)C(=O)O)NC(=O)CSC(=O)N | ||||
InChI | 1S/C10H10N2O4S/c11-10(16)17-5-8(13)12-7-4-2-1-3-6(7)9(14)15/h1-4H,5H2,(H2,11,16)(H,12,13)(H,14,15) | ||||
InChIKey | NWUAPELPCMQTDN-UHFFFAOYSA-N | ||||
PubChem Compound ID | 224665 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5J94 Human cathepsin K mutant C25S in complex with the allosteric effector NSC13345 | ||||||
Method | X-ray diffraction | Resolution | 2.22 Å | Mutation | Yes | [1] |
PDB Sequence |
YIPEWEGRAP
2 DSVDYRKKGY12 VTPVKNQGQC22 GSSWAFSSVG32 ALEGQLKKKT42 GKLLNLSPQN 52 LVDCVSENDG62 CGGGYMTNAF72 QYVQKNRGID82 SEDAYPYVGQ92 EESCMYNPTG 102 KAAKCRGYRE112 IPEGNEKALK122 RAVARVGPVS132 VAIDASLTSF142 QFYSKGVYYD 152 ESCNSDNLNH162 AVLAVGYGIQ172 KGNKHWIIKN182 SWGENWGNKG192 YILMARNKNN 202 ACGIANLASF212 PKM
|
|||||
|
||||||
PDB ID: 6ASH Crystal structure of human Cathepsin K with a non-active site inhibitor at 1.42 Angstrom resolution | ||||||
Method | X-ray diffraction | Resolution | 1.42 Å | Mutation | Yes | [2] |
PDB Sequence |
APDSVDYRKK
10 GYVTPVKNQG20 QCGSCWAFSS30 VGALEGQLKK40 KTGKLLNLAP50 QNLVDCVSEN 60 DGCGGGYMTN70 AFQYVQKNRG80 IDSEDAYPYV90 GQEESCMYNP100 TGKAAKCRGY 110 REIPEGNEKA120 LKRAVARVGP130 VSVAIDASLT140 SFQFYSKGVY150 YDESCNSDNL 160 NHAVLAVGYG170 IQKGNKHWII180 KNSWGENWGN190 KGYILMARNK200 NNACGIANLA 210 SFPKM
|
|||||
|
ASN18
3.386
GLN19
4.017
GLY20
3.297
GLN21
4.870
ASP55
4.700
CYS56
3.148
VAL57
4.364
SER58
2.569
GLU59
4.777
TYR74
3.583
LYS77
3.878
ASN78
3.457
CYS96
3.628
GLU112
4.417
ILE113
3.854
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods. Nat Commun. 2014;5:3287. | ||||
REF 2 | Crystal structure of human Cathepsin K with a non-active site inhibitor at 1.42 Angstrom resolution. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.